Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry
Xiaofang Tang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuejin Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xueyan Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Shubin Qiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingang Yang(Southwest University), Zhan Gao(First Affiliated Hospital of Wenzhou Medical University), Lifu Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhifang Wang(Xinxiang Central Hospital), Jinqing Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 9
Related Papers
Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance
|Stem Cell Research & Therapy|2019|157
The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China
|American Heart Journal|2015|133
2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions
|Journal of the American College of Cardiology|2022|98
The impact of fasting stress hyperglycemia ratio, fasting plasma glucose and hemoglobin A1c on in-hospital mortality in patients with and without diabetes: findings from the China acute myocardial infarction registry
|Cardiovascular Diabetology|2023|97
Stress hyperglycemia ratio and long‐term mortality after acute myocardial infarction in patients with and without diabetes: A prospective, nationwide, and multicentre registry
|Diabetes/Metabolism Research and Reviews|2022|74